Dr. Joan Attia | Cosmetics | Industry Summit Leadership Award
Dr. Joan Attia | Lucas Meyer Cosmetics | France
Dr. Joan Attia is an accomplished research leader and innovator in the field of skin science and therapeutic pharmacology. She currently serves as Head of Global R&D, overseeing the development of sustainable and advanced cosmetic ingredients. With a strong foundation in neuroscience and biomolecules, her career has been defined by bridging scientific discovery with industrial application. She pioneered early work in medical device development for skin repair and later advanced to lead international research teams. Her leadership at Lucas Meyer Cosmetics and Clariant has been instrumental in creating groundbreaking active and functional ingredients that combine sustainability with effectiveness. A prolific contributor to peer-reviewed journals, Dr. Attia has focused on skin microbiota, inflammation, peptides, and novel delivery systems that enhance skin health and beauty. She is recognized for her ability to merge diverse research teams and foster innovation, making her a leading figure in the intersection of industry and science.
Publication Profile
Orcid
Education
Dr. Joan Attia pursued higher education in the fields of neuroscience and therapeutic pharmacology, developing a robust academic background that combines biological sciences with applied medical research. She earned a master’s degree in neuroscience which provided her with a comprehensive understanding of brain and skin interactions, neurochemical signaling, and biological processes related to health and wellbeing. She furthered her academic journey with a doctorate in biomolecules and therapeutic pharmacology where she specialized in peptides, molecular interactions, and their therapeutic applications in skin repair and regeneration. Her doctoral research equipped her with expertise in experimental design, translational research, and therapeutic innovation, which became the cornerstone of her industrial career. This combination of neuroscience and pharmacology has enabled her to apply scientific rigor to the creation of functional and active ingredients for the cosmetics industry. Her academic foundation remains deeply tied to her leadership in global research and development.
Experience
Dr. Joan Attia has accumulated extensive experience in the field of skin research, industrial innovation, and global research leadership. Her career began with pioneering contributions to the development of medical devices for skin repair, where she applied her expertise in biomolecules to practical therapeutic solutions. She then joined Lucas Meyer Cosmetics, where she advanced within the R&D department to lead initiatives on biological screening platforms and the creation of new active ingredients. Her leadership role expanded when she became head of global research and development, managing international teams and projects focused on active and functional ingredients, raw material design, and sustainable delivery systems. Following the acquisition of Lucas Meyer Cosmetics by Clariant, she successfully integrated global R&D teams across multiple countries, fostering collaboration and continued innovation. Her experience demonstrates a strong balance of technical expertise, leadership capacity, and the ability to translate research findings into industry-shaping solutions.
Research Focus
Dr. Joan Attia’s research focuses on the intersection of skin health, therapeutic pharmacology, and industrial application. She has concentrated on developing novel peptides, plant extracts, and biomimetic molecules that strengthen skin function, enhance beauty, and address dermatological conditions. Her studies emphasize skin microbiota balance, the modulation of inflammatory pathways, and the development of non-aggressive therapeutic solutions for acne, scalp health, and skin aging. She has explored neurochemical signaling and stress-related inflammation, linking psychological factors to skin health outcomes. Her work extends to designing sustainable raw materials and innovative delivery systems, advancing functional and active ingredient science. She has applied both in vitro and in vivo models to validate efficacy, creating translational solutions that meet the needs of both consumers and industry. By combining molecular pharmacology, neuroscience, and design thinking, her research contributes to sustainable innovation, shaping the future of cosmetics and therapeutic dermatology.
Publication Top Notes
-
Strengthening the Skin Barrier by Using a Late Cornified Envelope 6A-Derived Biomimetic Peptide
-
A Hylocereus undatus Extract Enhances Skin Microbiota Balance and Delivers In-Vivo Improvements in Skin Health and Beauty
-
Lysine-Dendrimer, a New Non-Aggressive Solution to Rebalance the Microbiota of Acne-Prone Skin
-
Targeting inflammation and pro-resolving mediators with Anetholea anisita extract to improve scalp condition
Conclusion
Dr. Joan Attia stands out as a strong candidate for the Research for Industry Summit Leadership Award. Her ability to translate complex scientific discoveries into impactful industrial solutions demonstrates the very spirit of this recognition. With her leadership in R&D, innovation in sustainable ingredients, and consistent research contributions, she embodies the bridge between academic science and industrial advancement, making her highly suitable for this honor.